Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Following Huge Thing: 5 Progressive Tech New businesses - 2This is Countdown, CNN’s newsletter covering NASA’s first time sending humans to deep space in over 50 years
- 3FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- 4Native Americans had dice and games of probability long before other cultures, study finds
- 5One killed, several injured in Iran missile barrage on southern, central Israel
- the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
- Must-See Attractions in Washington, D.C.
- Misremembering might actually be a sign your memory is working optimally
- As tetanus vaccination rates decline, doctors worry about rising case numbers
- Iran-backed Iraqi militias attack Kurdistan over 450 times since beginning of war
- Lily Allen 2026 'West End Girl' arena tour: How to get tickets, prices and more
- Dolly Parton misses Dollywood event due to 'a few health challenges' after skipping honorary Oscars
- Arctic sea ice hits lowest winter level as unprecedented heat hits smashes records all over Earth
- Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny
